Dr Charlotte Tye is a Senior Lecturer in Psychology and Epilepsy Research Institute UK/Autistica Fellow in the Department of Psychology at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN).

Her research focuses on characterising development in young children with rare neurogenetic conditions and epilepsy, with the aim of identifying early predictors of later-emerging neurodevelopmental conditions and mental health difficulties. She leads the NEST Lab and is Principal Investigator on three prospective longitudinal studies:

• Tuberous Sclerosis 2000 (TS2000) Study
• Early Development in Tuberous Sclerosis (EDiTS) Study
• Brain development in Early Epilepsy (BEE) Study

Dr Tye holds a BSc in Experimental Psychology from the University of Bristol. She joined King’s College London in 2008 to complete an MSc and PhD at the Social, Genetic & Developmental Psychiatry Centre at the IoPPN. Her postdoctoral training took place in the Department of Child & Adolescent Psychiatry, with international placements at the University of California, Los Angeles and the University of Melbourne.

She has been awarded fellowships from the Tuberous Sclerosis Association, Epilepsy Research UK, and Autistica. In recognition of her contributions to developmental neuroscience, she received the Vicky H. Whittemore Prize (2015), the British Academy of Childhood Disability/Castang Foundation Fellowship (2019), and the 2023 British Psychological Society Developmental Section Margaret Donaldson Early Career Prize.

Research interests

• Neurodevelopmental conditions
• Neurocognitive development (EEG, eye-tracking, cognition)
• Epilepsy
• Rare genetic syndromes, with a focus on tuberous sclerosis complex (TSC)
• Prospective longitudinal cohorts

Teaching

• Psychological Skills: EEG Skill, BSc Psychology (Year 2)
• Early Neurocognitive Development, BSc Psychology (Year 3)
• Final year project supervision, BSc Psychology (Year 3)

Expertise and public engagement

• Patient/public involvement and engagement lead for the national MRC/NIHR-funded mTOR Pathway Diseases node
• Core partnerships with patient organisations and the community with integrated PPIE throughout research pipeline
• Member of the Epilepsy Research Institute UK Scientific Advisory Panel
• Member of the Epilepsy Research Institute UK Neurodevelopment Theme
• Member of the International League Against Epilepsy Paediatric Psychiatric Issues Task Force